@carlheneghan mindfully preparing for his talk on why we need a UK Sunshine Act to help solve the problem of conflicts of interest in medicine @OxEBHC @CebmOxford @EBM_Live @OxPrimaryCare
#COI #EBM
Starts with the story of Rofecoxib (Vioxx).
Presents the evidence that didn’t get into the NEJM because one of the study authors was a paid consultant on the drug company producing Vioxx.
#COI #EBM #EBMmanifesto
Carl recalls that he prescribed Vioxx and is vexed by the probability of harm he may have caused. Due to a COI impacting on the evidence he used to inform his medical practice.
And this was preventable if a better system was in place.
This slide is always revealing.
“Conflicts don’t impact on me. But they do on my peers”.
amjmed.com/article/S0002-…
Another great paper on the impact of bias and blind spots on interpretations of evidence resulting from COI.
A great slide on the efforts that have been made to date on tackling COIs in research.
Introducing the Sunshine Act in the US.
bmj.com/content/347/bm…
The UK doesn’t have the equivalent of the Sunshine Act. What was agreed was the ABPI proposal. The key issue = it’s VOLUNTARY.
That presents problems, as @bengoldacre neatly points out.
Voluntary systems DO NOT WORK.
Others have realised this. And acted.
Look at this list. All countries outside the US who have a Sunshine Act on DOIs. It’s revealing based on OMISSIONS not inclusions.
#COI #EBM #EBMmanifesto
Carl’s paper with @mgtmccartney in @TheLancet puts the issues forward.
And they are starting this website (will share link if I find it). Just a small matter of waiting for @GOVUK and @gmcuk to make this standard practice. #whatareyouwaitingfor
#COI #EBM #EBMmanifesto
Share this Scrolly Tale with your friends.
A Scrolly Tale is a new way to read Twitter threads with a more visually immersive experience.
Discover more beautiful Scrolly Tales like this.